MUTAMYCIN (Accord BioPharma Inc.)


Welcome to the PulseAid listing for the MUTAMYCIN drug offered from Accord BioPharma Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Accord BioPharma Inc.
NON-PROPRIETARY NAME: Mitomycin
SUBSTANCE NAME: MITOMYCIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-07-25
END MARKETING DATE: 0000-00-00


MUTAMYCIN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMUTAMYCIN from Accord BioPharma Inc.
LABELER NAME: Accord BioPharma Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/10mL)
START MARKETING DATE: 2017-07-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69448-001_55ab68d0-c46a-2f41-e054-00144ff88e88
PRODUCT NDC: 69448-001
APPLICATION NUMBER: ANDA064144

Other MITOMYCIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord BioPharma Inc.MUTAMYCIN
Accord Healthcare IncMitomycin